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Edited by Masayuki MiyasakaAbstract The locations at which vascular endothelial cells
recruit leukocytes during physiological or pathological inﬂam-
matory responses are inﬂuenced by direct eﬀects of local
haemodynamics on leukocyte adhesion. However, the expression
of genes by endothelial cells, and their ability to respond to
inﬂammatory cytokines also depend on the ﬂow forces to which
they are exposed. In addition, cells of the underlying stroma can
modify the phenotype and responsiveness of endothelial cells, and
hence their ability to recruit leukocytes. Thus, endothelial cells
are plastic in their responses, and we hypothesise that the pattern
of recruitment of leukocytes to tissues is critically dependent on
the variable modulation of the endothelium by the local
physicochemical microenvironment.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Inﬂammation; Leukocyte recruitment1. Introduction – endothelial recruitment of leukocytes in
inﬂammation and regulation by the local environment
Endothelial cells (ECs) contribute to the regulation of vas-
cular tone, haemostasis, angiogenesis, and passage of soluble
compounds and cells of the immune system to and from tissue.
Of particular importance during inﬂammatory responses is the
ability of vascular EC to both initiate and control the recruit-
ment of leukocytes [1,2]. They achieve this by responding to
cytokines and other inﬂammatory agonists, to modify surface
expression of adhesion receptors and chemokines required for
the capture of leukocytes from the ﬂowing blood and migration
into tissue. However, the characteristics or phenotype of EC
vary between diﬀerent levels of the vascular tree and between
diﬀerent organs, with respect to patterns of gene expression,
morphology, secretory potential and permeability [3,4]. This
variation also applies to their ability to support adhesion and
migration of leukocytes. Endothelium in venules of lymphatic
organs is specialised for continuous capture and migration of
recirculating lymphocytes, and post-capillary venules of other
tissues are typically the dominant sites for phased recruitment of* Corresponding author. Fax: +44-121-414-6919.
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doi:10.1016/j.febslet.2004.05.040granulocytes and mononuclear cells following inﬂammatory
insult.
There is much evidence that the phenotype of ECs in dif-
ferent vessels may be conditioned by the varying haemody-
namic forces exerted on them from the vascular lumen, and by
interactions with the underlying substrate and stromal cells
(e.g. [3,5,6] and Table 1). Thus, it has been suggested that even
within a single organ such as the lung, diﬀerent haemodynamic
and stromal conditioning of the ECs in alveolar vs. bronchial
microcirculation, might explain the diﬀerent adhesive mecha-
nisms used for leukocyte recruitment in those regions [7]. Even
after isolation from their normal environment, ECs from dif-
ferent sources can retain diﬀerent adhesive characteristics, al-
though generally their phenotype converges with time. It was
shown recently that EC isolated from heart or lung of mice
both supported adhesion of ﬂowing T-cells but that the be-
haviour of the adherent T-cells and the chemokines utilised for
their recruitment diﬀered [8]. In humans, primary cultures of
sinusoidal ECs from liver retain speciﬁc adhesion receptors for
lymphocyte migration [9], not found for instance in more
widely studied human umbilical vein ECs.
Fig. 1 illustrates the steps by which ﬂowing leukocytes attach
to and migrate through ECs which have been exposed to in-
ﬂammatory cytokines, and the local environmental factors that
may inﬂuence this process. While the propensity for ECs to
recruit leukocytes is likely to be conditioned by ﬂuid forces and
stromal cells, direct evidence has only become available re-
cently (e.g. [10–12]). Here, we advance the speciﬁc hypothesis
that the sensitivity of ECs to inﬂammatory mediators and the
ability to recruit leukocytes are modulated by local conditions.2. Direct and indirect eﬀects of haemodynamics on leukocyte
adhesion and migration
During inﬂammation, leukocyte recruitment occurs typically
in the microcirculation in post-capillary venules where the wall
shear stress (i.e. the frictional force exerted by the ﬂowing blood
on the vessel wall) is relatively low, and not in adjacent arte-
rioles with higher shear stresses [13]. Increasing shear forces
generally reduces the eﬃciency with which cells can attach to an
adhesive surface. However, the diﬀerences in recruitment be-
tween vessels cannot be explained by the direct physical eﬀects
of ﬂow on adhesion alone. Acute artiﬁcal reduction in ﬂow rate
through arterioles in inﬂammed tissue did not induce adhesionblished by Elsevier B.V. All rights reserved.
Table 1
Examples of eﬀects of co-culture with diﬀerent stromal cells on func-
tions of ECs
Cell type Endothelial response modiﬁed
Smooth muscle cells Inhibited EC growth [48]; increased
expression of adhesion molecules and
leukocyte recruitment [11,38,40]
Alveolar epithelial cells Increased adhesion of leukocytes [39]
Pericytes EC growth and angiogenesis [48,49]
Fibroblasts (skin) Formation of endothelial tube structures
[50]
Astrocytes Permeability of monolayers [51]
Glomerular epithelial cells
(podocytes)
Augmentation of ‘angiogenic’ response
[52]
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the ECs were themselves diﬀerent [14]. Comparative studies of
arterioles and venules of the inﬂammed heart [15] or lungs [16]
have supported the concept that endothelial as well as hae-
modynamic factors inﬂuence leukocyte adhesion in these mi-
crovessels. Leukocytes do not normally adhere to the
endothelium of large arteries, possibly because local wall shear
stresses are too high. However, blood-derived monocyte/mac-
rophages and T-lymphocytes are found within atheromatous
plaques and are important promoters of the development of
these lesions [17]. Plaques form preferentially at bifurcations
and regions of vessel curvature where the laminar pattern of
blood ﬂow is disturbed [18]. In these regions vortices occur,
with regions of backﬂow (recirculation) and low wall shear
stress (e.g. [19]). Such disturbances may directly facilitate leu-
kocyte adhesion, but the local conditions may also modulate
the state of ECs so that they are more responsive to inﬂam-
matory mediators. Indeed, ECs covering plaques express cap-
ture receptors (selectins and vascular cell adhesion molecule-1,
VCAM-1), which are absent from healthy arteries [20,21].
The indirect (cell biological) eﬀects of shear stress on adhesion
are most probably mediated through the regulation of endo-Fig. 1. Schematic representation of the steps by which leukocytes, such as ne
physicochemical environmental factors which condition the contribution of E
stream (1) and are captured and form unstable rolling attachments (2) usi
message(s) from agents such as chemokines presented on the ECs cause the
receptors, and then to spread on the surface (4) and migrate ﬁrst over and the
integrin adhesion and cytoskeletal rearrangements. Stromal cells such as tissu
cytokines which induce the endothelial presentation of selectins and chemokin
cytokine milieu and condition the responses of ECs. Shear stress applied to E
responses to pro-inﬂammatory cytokines.thelial gene expression. Much attention has been paid in the last
decade to the ability of ECs to respond to haemodynamic forces,
chieﬂy shear stress, but also hydrostatic pressure which induces
circumferential strain in the vessel wall and cellular compression
[6]. It has become increasingly recognised that ECs can respond
to changes in shear force, rapidly by releasing vasoactive sub-
stances such as nitric oxide, or more slowly through modiﬁca-
tion of gene expression. Numerous studies have deﬁned changes
in expression of genes, including those encoding receptors and
chemokines relevant to leukocyte recruitment, when endothelial
cels are cultured at diﬀerent levels of shear stress (e.g. [10,22–
27]). Some such changes are transient and may not be strictly
relevant to the adhesive status of ECs which are continually
exposed to ﬂow. For instance, endothelial integrin ligand
ICAM-1 and the chemokine MCP-1 were upregulated upon
exposure to shear stress, but returned to basal level by 24 h
[26,28]. Moreover, changes in gene expression have rarely been
quantiﬁed when cytokine stimulation (which typically regulates
adhesion molecule expression in inﬂammation) and shear stress
are combined, while use of direct functional readouts such as
leukocyte migration has also been uncommon.
In fact, signalling responses and activation of gene tran-
scription factors induced by TNF are modiﬁed in ECs that
have been cultured under ﬂow even for quite short periods [29].
Perhaps more directly relevant to modulation of endothelial
inﬂammatory responses are recent studies where prolonged
periods of shear and cytokine treatment have been combined,
and subsequent ability of endothelial cells to recruit leukocyte
has been studied. Thus, we showed that exposing cultured ECs
to relatively low shear stress (0.3 Pa; approximating levels in
post-capillary venules) for increasing periods upto 24 h, stea-
dily decreased the response of the EC to TNF, as judged by
their ability to induce migration of adherent neutrophils [12].
When higher shear stresses were used (up to arterial levels of
2.0 Pa), the TNF treated ECs were no longer able to eﬃciently
capture ﬂowing neutrophils. The diﬀerential responses at lowutrophils, are recruited from blood into inﬂammed tissue, and the local
Cs to this process. Leukocytes become marginated by the central blood
ng selectin receptors expressed on the surface of the ECs. Activating
leukocytes to become immobilised (3) through their activated integrin
n through the endothelial monolayer (5) via co-ordinated regulation of
e-resident monocyte/macrophages release inﬂammatory mediators and
es. Other cells such as smooth muscle cells or ﬁbroblasts may add to the
Cs by the ﬂowing blood can modify their expression of genes and their
G.B. Nash et al. / FEBS Letters 569 (2004) 13–17 15and high shear stress were attributable to reduced ability to
upregulate chemokine and selectin expression, respectively. In
addition, others demonstrated recently that ECs lining the
aorta of rabbits showed reduced upregulation of VCAM-1 in
response to TNF treatment when the aorta was perfused ex
vivo at high compared to low shear stress [30].
These studies imply that ECs are conditioned by their shear
environment and can take on diﬀerent responsiveness to cy-
tokines, and hence ability to recruit leukocytes and mount an
inﬂammatory response. This ‘chronic’ conditioning might ap-
ply to diﬀerent regions of the circulation where shear levels are
continuously diﬀerent. However, given that EC can quickly
respond to changes in shear stress, acute shear modulation
might be important in conditions such as ischaemia and rep-
erfusion, or artiﬁcal cessation of ﬂow during surgery, where
sudden and relatively short-lived changes may occur. Indeed, it
has been shown that if EC are conditioned to shear ﬂow and it
is then ceased, they quickly respond by generating and oxi-
dative burst and then mobilise gene transcription factors [31].
It will be interesting to test whether responses to inﬂammatory
agents rapidly increase under these circumstances, or whether
hours are again necessary. In any case, the possibility arises
that the pro-inﬂammatory responses of ECs are not only
conditioned by their stable local ﬂow environment, but can
also ﬂuctuate depending on changes in that environment.3. Eﬀects of stromal factors on ability of ECs to support
leukocyte adhesion and migration
Endothelial cells exist in close contact with smooth muscle
cells and pericytes in the vessel wall, are juxtaposed to spec-
ialised cells in speciﬁc organs such as the brain (astrocytes),
liver (hepatocytes), kidneys (glomerular podocytes) and lungs
(alveoler epithelial cells), and are surrounded by less obviously
specialised ﬁbroblasts in all tissues. All of these cells are be-
lieved to be able to condition the responses of ECs and may
provide tissue-speciﬁcity (see Table 1 for examples). Macro-
phages and mast cells are resident in all tissue and can instigate
inﬂammatory responses by releasing fast-acting agents such as
histamine or cytokines tumour necrosis factor-a (TNF) and
interleukin-1b (IL-1) [32]. These agents are capable of inducing
ECs to support some or all of the stages of leukocyte recruit-
ment outlined in Fig. 1. Smooth muscle cells found in the wall
of most vessels above the size of capillaries have an essentially
structural function. However, in disease states such as ath-
erosclerosis they can transform to a secretory phenotype, re-
leasing a battery of compounds including chemokines (IL-8
and MCP-1) and in some contexts, IL-1 and TNF [17,33]. A
similar capability is found in tissue ﬁbroblasts, which again
classically have functions in structural support, but may also
release a variety of cytokines and chemokines capable of
modifying endothelial and leukocyte behaviour [34]. However,
while stromal cells are widely regarded as capable of modifying
inﬂammatory responses, their eﬀects on the ability of endo-
thelial cells to recruit leukocytes remain poorly deﬁned.
The matrix proteins to which ECs are attached might also
aﬀect phenotype [3]. For instance, the growth characteristics or
surface glycosylation of ECs are modiﬁed when cultured on
speciﬁc components of extracellular matrix or matrices derived
from diﬀerent organs [35,36]. Recent studies in our laboratory
indicate that in prolonged cultures, ECs progressively depositmatrix proteins and change their sensitivity to cytokine stim-
ulation. However, a direct link between the two responses is
unproven so far. Interestingly, responses of ECs to shear stress
appear to originate from or are at least modulated by signals
arising from integrins engaged with matrix proteins [37]. Thus,
while the eﬀects of interactions with speciﬁc substrate proteins
on endothelial adhesive phenotype are uncertain, there appears
to be a strong likelihood that the response to the physical
environment, at least, will be modulated at this level.
It is diﬃcult to unequivocally demonstrate that in vivo
variations in endothelial inﬂammatory responses arise from
their stromal environment. However, in vitro co-culture of ECs
with stromal cells is known to modify a range of responses of
ECs (Table 1). Of particular relevance here, are the ﬁndings
that ECs cultured with smooth muscle cells had augmented
response to oxidised low density lipoprotein judged by ability
to bind monocytic cells [38]. Moreover, ECs co-cultured with
alveolar epithelial cells showed increased recruitment of
mononuclear leukocytes upon cytokine stimulation [39]. We
showed recently that smooth muscle cells in their secretory state
(i.e., as found in atheromatous arteries) did not themselves
cause ECs to become adhesive, but did greatly increase the
response of ECs to TNF [11]. This was manifest as more eﬃ-
cient binding of ﬂowing lymphocytes, monocytes and neutro-
phils, and ability to initiate binding at much lower levels of
TNF. Others have found that co-culture alone caused upreg-
ulation of mRNA for adhesion receptors ICAM-1, E-selectin
and VCAM-1, although adhesive functional eﬀects were not
reported [40]. It is possible that the apparent discrepancy might
arise from diﬀerent conditions of co-culture (growth factors,
substrate, etc.). Interestingly, in a rare combination of stromal
and physical environmental modulation, the ‘intrinsic’ receptor
upregulation in co-cultures was modiﬁed when the co-cultured
ECs were exposed to arterial levels of ﬂuid shear stress [40].
Skin ﬁbroblasts do not appear to have the same stimulatory
capacity as smooth muscle cells [41], but this may not be the
case in inﬂammed tissue. For instance, ﬁbroblasts from ar-
thritic synovium release elevated levels of cytokines such as IL-
6 and MCP-1, and have been shown to modulate retention of
lymphocytes in tissue, and to alter their migrational behaviour
[34,42]. We are currently investigating whether in co-culture
they can directly induce or modify endothelial recruitment of
leukocytes. In fact it is likely that an evolving stromal envi-
ronment plays a key role in the development of chronic in-
ﬂammatory pathology, in part at least by modifying the
responses of ECs. Recruited leukocytes such as T-cells and
monocytes may also provide positive feedback [43,44]. Mono-
cytes are able to directly induce ECs to upregulate adhesion
receptors and support capture of ﬂowing leukocytes [45]. This
pro-inﬂammatory capability may decline during normal mat-
uration into macrophages [46]. However, in abnormal tissues
such as atheroma or the pannus of the rheumatoid joint, the
monocyte-derived cells may themselves take on phenotypes
(foam cells or type B cells respectively) that promote a pro-
inﬂammatory state via interaction with endothelium.4. Pathophysiological signiﬁcance of endothelial conditioning in
inﬂammation
The foregoing has implications for the regulation of
‘physiological’ protective inﬂammatory responses, and for
16 G.B. Nash et al. / FEBS Letters 569 (2004) 13–17the institution and progression of pathologies linked to ab-
errant recruitment of leukocytes. Limitation of the sensitivity
of ECs to cytokines at speciﬁc sites may allow controlled,
local recruitment. Moreover, speciﬁc niches in organs may
induce receptors peculiar to that tissue and adapted for its
function (e.g. liver, lymph nodes, lungs). On the other hand,
the local ﬂow conditions, or changes in stroma may lead to
predilection to disease. Atheroma typically forms in regions
of arteries with complex patterns of low shear ﬂow [18],
which are believed to alter EC phenotype as well as directly
aﬀecting leukocyte recruitment to the wall [19,37]. Moreover,
transformation of SMC to secretory phenotype may make
the local EC more sensitive to circulating inﬂammatory cy-
tokines and accelerate disease progression [11]. Acute chan-
ges in local conditions might also inﬂuence disease
progression. During ischaemia, ECs might be conditioned so
that they respond strongly upon return of ﬂow (reperfusion)
[31]. This might inﬂuence development of tissue infarcts, as
well as outcome of surgical procedures or organ transplan-
tation. It is also interesting to speculate that the typical
increase in blood ﬂow arising from arteriolar dilation at
onset of inﬂammation could have a feedback eﬀect on re-
sponsiveness of venular endothelium downstream. Moreover,
progression to chronic disorders and failure to resolve in-
ﬂammation could arise from changes in local stroma, which
might be thought of as a ‘rheostat’ that is reset in persistent
inﬂammation [47]. Thus in RA joint, there is proliferation
and transformation of ﬁbroblasts and macrophages in the
developing panus. Local vessels develop with endothelial
architecture reminiscent of lymphatics rather than post-cap-
illary venules, and there is prolonged recruitment of all types
of leukocytes with speciﬁc T-cells subsets retained in the
tissue. While these features cannot all be attributed to
changes in the endothelial phenotype, it may play a signiﬁ-
cant role.5. Summary
In summary, we hypothesise that ECs are pliable cells whose
pro-inﬂammatory phenotype is variable and not necessarily set
for life. Their ability to upregulate expression of adhesion re-
ceptors and cytokines, and thus to support an inﬂammatory
responses by recruiting leukocytes, are determined by their
local physicochemical environment. Not only are the haemo-
dynamic and stromal environments peculiar to speciﬁc types of
vessel or organ, but they may be modiﬁed in disease states. By
analogy to the adhesion receptors and chemokine ‘post-code’
for leukocyte recruitment borne by endothelium, there might
eﬀectively be a tissue post-code that conditions the EC re-
sponses. This tissue postcode may not only be important in
determining sites or severity of initial inﬂammatory responses,
but will also inﬂuence resolution of inﬂammation or its
transformation to a chronic state.References
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